Sudarshan Sukhani of s2analytics.com said, "For the last 12 months, Rs 1,040 has been resistance for Infosys on the charts. So, the stock should be bought into once that resistance is crossed. It is not very far, 10-12 percent. I would feel that just entering into this trading range where it is bouncing will not give any results. I would wait patiently for that level if it is crossed and then only venture into it."

Sudarshan further added, "The market is not giving a very comfortable impression to me and there are intraday buying opportunities in the Nifty, maybe swing trading, perhaps the view is on the downside. It is very confusing."

"Ajanta Pharma is a short sell. I think in pharmaceutical probably more lower levels are coming. The bear market in pharmaceutical is not over. When it is over it will become dream buy, but that is when it happens, not now." he aforesaid.

"Balkrishna Industries which was an erstwhile high-flyer, is now distributing, giving a sense of a strong bear pattern and that could go much lower. It is a short sell," he said.

Also Read:

9 more people lost their lives due to Swine Flu in Gujarat

Shaista Ambar demands to create a Muslim Marriage Act on the lines of the Hindu Marriage Act

Triple talaq verdict: Supreme Court ban the practice, Parliament must bring law